TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 55 filers reported holding TALARIS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,240,623 | -7.6% | 2,932,606 | 0.0% | 10.94% | +16.8% |
| Q2 2023 | $8,915,122 | +61.7% | 2,932,606 | 0.0% | 9.37% | +40.4% |
| Q1 2023 | $5,513,299 | +84.3% | 2,932,606 | 0.0% | 6.67% | +68.6% |
| Q4 2022 | $2,991,258 | -61.2% | 2,932,606 | 0.0% | 3.96% | -64.7% |
| Q3 2022 | $7,713,000 | -41.7% | 2,932,606 | 0.0% | 11.20% | -39.0% |
| Q2 2022 | $13,226,000 | -54.2% | 2,932,606 | 0.0% | 18.36% | -32.3% |
| Q1 2022 | $28,857,000 | -35.6% | 2,932,606 | 0.0% | 27.11% | +31.4% |
| Q4 2021 | $44,840,000 | – | 2,932,606 | – | 20.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $5,513,299 | 6.67% |
| BML Capital Management, LLC | 1,929,484 | $3,627,430 | 3.14% |
| Western Standard LLC | 586,481 | $1,102,584 | 1.12% |
| Cormorant Asset Management, LP | 900,649 | $1,693 | 0.11% |
| Artal Group S.A. | 914,262 | $1,719 | 0.10% |
| Values First Advisors, Inc. | 52,896 | $99,445 | 0.06% |
| Blackstone Inc. | 8,089,315 | $15,207,912 | 0.06% |
| Eventide Asset Management | 1,561,092 | $2,934,853 | 0.05% |
| Marquette Asset Management, LLC | 101,375 | $190,585 | 0.05% |
| VIKING GLOBAL INVESTORS LP | 3,289,617 | $6,184,480 | 0.03% |